Skip to main content

Table 2 Cointerventions received according to corticosteroid treatment status among critically ill patients with H1N1pdm09

From: The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness

Cointervention All patientsa (n = 607) Not treated with corticosteroids (n = 327) Treated with corticosteroids (n = 280) p Value
Mechanical ventilation, day 1 392 (66.2) 212 (67.5) 180 (64.8) 0.48
Mechanical ventilation, any 535 (89.2) 275 (85.4) 260 (93.5) 0.001
Rescue oxygenation strategy, any 98 (16.1) 39 (11.9) 59 (21.1) 0.002
 ECMO 18 (3.0) 10 (3.1) 8 (2.9) 0.88
 HFOV 61 (10.1) 27 (8.3) 34 (12.1) 0.11
Nitric oxide 52 (8.6) 21 (6.4) 31 (11.1) 0.04
Prone ventilation 11 (1.8) 3 (0.9) 8 (2.9) 0.07
Antibiotic treatment, day 1 382 (63.9) 199 (60.9) 183 (65.4) 0.25
Antibiotic treatment, any 588 (96.9) 317 (96.9) 271 (96.8) 0.91
Neuraminidase inhibitor treatment, day 1 316 (52.1) 166 (50.8) 150 (53.6) 0.49
Neuraminidase inhibitor treatment, any 564 (92.9) 294 (89.9) 270 (96.4) 0.002
Vasopressor treatment, day 1 251 (41.4) 131 (40.1) 120 (42.9) 0.49
Vasopressor treatment, any 334 (55.0) 171 (52.3) 163 (58.2) 0.14
  1. ECMO extracorporeal membrane oxygenation; HFOV high-frequency oscillation ventilation; Day 1 first day in intensive care unit
  2. Data are presented as number (%). Some patients received more than 1 rescue strategy.
  3. aDenominators may vary for each category